Drug Information

Drug General Information
Drug ID
D0EG5A
Former ID
DNCL002641
Drug Name
Retaspimycin
Drug Type
Small molecular drug
Indication Non-small cell lung cancer [ICD10:C33-C34] Discontinued in Phase 2 [548101]
Company
Infinity Pharmaceuticals
Structure
Download
2D MOL

3D MOL
Formula
C31H45N3O8
Canonical SMILES
CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=C(C(=C2O)C1)NCC=C<br />)O)C)OC)OC(=O)N)C)C)O)OC
InChI
1S/C31H45N3O8/c1-8-12-33-26-21-13-17(2)14-25(41-7)27(36)19(4)15-20(5)29(42-31(32)39)24(40-6)11-9-10-18(3)30(38)34-22(28(21)37)16-23(26)35/h8-11,15-17,19,24-25,27,29,33,35-37H,1,12-14H2,2-7H3,(H2,32,39)(H,34,38)/b11-9-,18-10+,20-15+/t17-,19+,24+,25+,27-,29+/m1/s1
InChIKey
OAKGNIRUXAZDQF-TXHRRWQRSA-N
PubChem Compound ID
11534420
PubChem Substance ID
16636399, 23659384, 76164045, 96026055, 126679887, 139902652, 160671805, 160962959, 198946744, 223683299, 237344520, 238198836
References
Ref 548101Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021934)

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.